Effect Of Detrol LA With Behavioral Intervention In Overactive Bladder Subjects Dissatisfied With Recent OAB Medication.

Completed · Phase 4

Conditions studied: Urinary Incontinence

In brief

To evaluate the effect of tolterodine ER in conjunction with behavioral intervention on subject satisfaction in OAB subjects who were dissatisfied with their most recent antimuscarinic OAB medication therapy.

Key facts

Study ID

NCT00230789

Run by

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

People needed

417

Starts

2005-10-01

Expected to finish

2006-12-01

Last updated by the study team

2021-01-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male and female subjects greater than or equal to 18 years of age
• Overactive bladder symptoms for at least 3 months
• Previously treated with antimuscarinic OAB medications

You may not qualify if…

• Participation in any professionally coached sessions (RN, NP, PA or PT) teaching behavioral interventions

Where it is running

• Pfizer Investigational Site — Sun Lakes, Arizona, United States
• Pfizer Investigational Site — Little Rock, Arkansas, United States
• Pfizer Investigational Site — Beverly Hills, California, United States
• Pfizer Investigational Site — Buena Park, California, United States
• Pfizer Investigational Site — Mission Viejo, California, United States
• Pfizer Investigational Site — Modesto, California, United States
• Pfizer Investigational Site — Oceanside, California, United States
• Pfizer Investigational Site — Paramount, California, United States
• Pfizer Investigational Site — Sacramento, California, United States
• Pfizer Investigational Site — Torrance, California, United States
• Pfizer Investigational Site — Tustin, California, United States
• Pfizer Investigational Site — Colorado Springs, Colorado, United States
• Pfizer Investigational Site — Wheat Ridge, Colorado, United States
• Pfizer Investigational Site — Hallandale, Florida, United States
• Pfizer Investigational Site — Orlando, Florida, United States
• Pfizer Investigational Site — Wellington, Florida, United States
• Pfizer Investigational Site — Woodstock, Georgia, United States
• Pfizer Investigational Site — Libertyville, Illinois, United States
• Pfizer Investigational Site — Mattoon, Illinois, United States
• Pfizer Investigational Site — Newton, Kansas, United States
• Pfizer Investigational Site — Milford, Massachusetts, United States
• Pfizer Investigational Site — Manchester, Missouri, United States
• Pfizer Investigational Site — St Louis, Missouri, United States
• Pfizer Investigational Site — Westhampton, New Jersey, United States
• Pfizer Investigational Site — Phoenix, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.